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Abstract
Aim: To determine whether novobiocin resistance strategy could be used to
attenuate a virulent Aeromonas hydrophila AH11P strain and to characterize
the growth and pathogenic differences between the novobiocin-resistant strain
and its virulent parent strain AH11P.
Methods and Results: A novobiocin-resistant strain AH11NOVO was obtained
from a virulent Aer. hydrophila strain AH11P through selection of resistance to
novobiocin. AH11NOVO was found to be avirulent to channel catfish
(Ictalurus punctatus), whereas AH11P was virulent. When AH11NOVO
vaccinated channel catfish were challenged with AH11P at 14 days
postvaccination, relative per cent of survival of vaccinated fish was 100%. The
cell proliferation rate of AH11NOVO was found to be significantly (P < 005)
less than that of AH11P. In vitro motility assay revealed that AH11NOVO was
nonmotile, whereas AH11P was motile. AH11NOVO had significantly
(P < 005) lower in vitro chemotactic response to catfish mucus than that of
AH11P. Although the ability of AH11NOVO to attach catfish gill cells was
similar to that of AH11P, the ability of AH11NOVO to invade catfish gill cells
was significantly (P < 005) lower than that of AH11P.
Conclusions: The novobiocin-resistant AH11NOVO is attenuated and
different from its parent AH11P in pathogenicity.
Significance and Impact of the Study: The significantly lower chemotactic
response and invasion ability of AH11NOVO compared with that of its
virulent parent strain AH11P might shed light on the pathogenesis of
Aer. hydrophila.
Introduction
Aeromonas hydrophila, a Gram-negative, motile, rod-
shaped bacterium commonly found in aquatic environ-
ments throughout the world, is the causative agent of
motile aeromonad septicaemia (MAS; Harikrishnan et al.
2003), which is also known as epizootic ulcerative syn-
drome (Mastan and Qureshi 2001). The symptoms of
MAS include swelling of tissues, dropsy, red sores, necrosis,
ulceration and haemorrhagic septicaemia (Karunasagar
et al. 1989). Fish species affected by MAS include tilapia
(Abd-El-Rhman 2009; Tellez-Ban˜uelos et al. 2010), catfish
(Majumdar et al. 2007; Ullal et al. 2008), goldfish (Irianto
et al. 2003; Harikrishnan et al. 2009), common carp (Jeney
et al. 2009; Yin et al. 2009) and eel (Esteve et al. 1994).
Although usually considered as a secondary pathogen asso-
ciated with disease outbreaks, Aer. hydrophila could also
emerge as a primary pathogen (Pridgeon and Klesius
2011a), causing outbreaks in fish farms with high mortality
rates and severe economic losses to the aquaculture indus-
try worldwide.
To control MAS, feeding infected fish with antibiotic-
medicated feed is a general practice (DePaola et al. 1995).
However, this practice is expensive and usually ineffective
as sick fish tend to remain off feed. In addition, MAS
caused by Aer. hydrophila can be very acute, causing
Journal of Applied Microbiology 113, 1319--1328 © 2012 No claim to US Government works 1319
Journal of Applied Microbiology ISSN 1364-5072
mortality within 24 h (Pridgeon and Klesius 2011a). Fur-
thermore, there are only three antibiotics currently
approved by FDA for use in aquaculture: oxytetracycline
(Terramycin), sulfadimethoxine (Romet-30) and florfeni-
col (Aquaflor). The widespread use of the limited number
of antibiotics for treating bacterial diseases in aquaculture
has led to the development of antibiotic resistance in
many fish pathogens worldwide (Pridgeon et al. 2011).
Therefore, alternative control methods are urgently
needed for the aquaculture industry.
Use of vaccine is an alternative control method to pre-
vent MAS. The most extensively studied Aer. hydrophila
vaccines are bacterins consisting of formalin or heat-
killed bacteria of pathogenic Aer. hydrophila strains
(Ruangpan et al. 1986; Chandran et al. 2002; John et al.
2002). In addition, recombinant protein vaccines such as
Aer. hydrophila outer membrane proteins and bacterial
lysates have been demonstrated to elicit protection
against Aer. hydrophila challenge (Khushiramani et al.
2007; LaPatra et al. 2010; Poobalane et al. 2010; Guan
et al. 2011). Furthermore, live attenuated vaccines such
as aroA mutant and transposon Tn916-generated mutants
have been reported to confer significant protection
against homologous Aer. hydrophila challenge (Hernanz
Moral et al. 1998; Liu and Bi 2007).
To develop effective live bacterial vaccines, novobiocin-
resistant strategy has been successfully used to attenuate
Edwardsiella ictaluri (Pridgeon and Klesius 2011b) and
Streptococcus iniae (Pridgeon and Klesius 2011c). In addi-
tion, attenuated Aer. hydrophila have been obtained
through selection for resistance to both novobiocin and
rifampicin (Pridgeon and Klesius 2011d). However, it is
currently unclear whether Aer. hydrophila strains could be
attenuated by novobiocin alone for the purpose of vac-
cine development. In addition, it is currently unknown
whether the trait of novobiocin resistance will affect the
growth and pathogenic characteristics of Aer. hydrophila,
such as chemotaxis, motility, attachment and invasion.
Therefore, the objectives of this study were as follows:
(i) To determine whether novobiocin-resistant strategy
could be used to attenuate a virulent Aer. hydrophila
AH11P strain; and (ii) To characterize the growth and
pathogenicity differences between the novobiocin-
resistant Aer. hydrophila AH11NOVO strain and its
virulent parent strain AH11P.
Materials and methods
Induction of novobiocin resistance in Aeromonas
hydrophila
Aeromonas hydrophila AH11P strain was obtained from
diseased channel catfish from Alabama in 2005. The
bacteria strain was identified by gas chromatography anal-
ysis of fatty acid methyl ester (FAME) using the MIDI
microbial identification system (MIDI, Newwark, DE,
USA) according to established procedures (Shoemaker
et al. 2005). The archived strain was recovered from frozen
stocks (2 ml aliquots stored at 80°C) and grown in tryp-
tic soy broth (TSB; Fisher Scientific, Pittsburgh, PA, USA)
for 24 h at 28°C. The recovered AH11P strain was used to
obtain the novobiocin-resistant strain AH11NOVO. Novo-
biocin sodium salt was purchased from Promega
(Madison, WI, USA). The initial concentration of novobi-
ocin that allowed growth of Aer. hydrophila was
10 lg ml1. After 20 passages of Aer. hydrophila AH11P
in TSB containing the same or higher concentrations of
novobiocin, the antibiotic-resistant strain AH11NOVO
was able to grow in TSB containing 9600 lg ml1 of
novobiocin. The parent strain AH11P and the novobiocin-
resistant strain AH11NOVO were then cultured on 5%
sheep blood agar plates (Thermo Fisher Scientific Remel
Products, Lenexa, KS, USA) for bacterial identification.
Bacteria strains were identified by gas chromatography
analysis of FAME using the MIDI microbial identification
system (MIDI) according to established procedures
(Shoemaker et al. 2005). In addition, DNA gyrase B gene
specific primers (forward 5′-AGTGTGCGTCCCAGGTA
TTC-3′ and reverse 5′-CTTCCTGATAGGCGTCGTTC-3′)
were used to amplify partial DNA gyrase B gene from both
strains by polymerase chain reaction (PCR) and the puri-
fied PCR products were subjected to DNA sequencing.
Virulence of the novobiocin-resistant Aeromonas
hydrophila AH11NOVO to channel catfish
All fish treatment protocols were approved by Institu-
tional Animal Care and Use Committee at the Aquatic
Animal Health Research Laboratory following related
guidelines. The health status of fish used in this study
was randomly checked by culturing kidney samples on
tryptic soy agar (TSA) plates. Only culture negative cat-
fish were considered healthy and therefore used in this
study. To study the virulence of the novobiocin-resistant
Aer. hydrophila strain AH11NOVO to healthy channel
catfish compared with its parent strain AH11P, all bacte-
ria were cultured overnight in TSB at 28°C. Optical den-
sity (OD) of the bacterial culture was measured at
540 nm and adjusted to OD = 10 using Thermospec-
tronic spectrophotomer (Fisher Scientific). Serial dilu-
tions of each strain (in triplicates) were then immediately
prepared in TSB, and 100 ll of serially diluted
Aer. hydrophila was plated on TSA plates immediately.
After the TSA, plates were incubated at 28°C for 24 h,
the average number of colony forming unit (CFU) per
millilitre was then calculated for both strains. Three
1320 Journal of Applied Microbiology 113, 1319--1328 © 2012 No claim to US Government works
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different doses (16 9 108, 80 9 107, and 16 9 107 col-
ony forming unit per fish) were used to determine
whether AH11NOVO was attenuated. Channel catfish
(mean weight of 12 ± 26 g) were exposed to AH11P or
AH11NOVO through intraperitoneal (IP) injection. All
channel catfish (Industry pool strain, USDA, ARS; Catfish
Genetics Research Unit, Stoneville, MS, USA) used in this
study were raised at the USDA-ARS Aquatic Animal
Health Research facility at Auburn, Alabama. A total of
60 fish were used in each treatment group (20 fish per
tank, three replicates). Published fish maintaining condi-
tions (Pridgeon and Klesius 2011b) were used in this
study. Mortalities were recorded daily for 14 days post
challenge and the presence or absence of Aer. hydrophila
in dead fish were determined from bacterial cultures
derived from the brain and kidney samples streaked on
blood agar plates followed by FAME analysis using MIDI
microbial identification system (MIDI).
Vaccination of channel catfish with AH11NOVO
followed by challenge with AH11P
The attenuated Aer. hydrophila AH11NOVO was cultured
in TSB broth at 28°C with shaking at 125 rev min1 over-
night before vaccination. Channel catfish were vaccinated
with 16 9 108 CFU per fish of the novobiocin-resistant
Aer. hydrophila AH11NOVO in a total volume of 100 ll
by IP injection. The vaccination dose of 16 9 108 CFU
per fish was chosen because this was the highest safe dose
of AH11NOVO to catfish used in this study. As sham-vac-
cination controls, 100 ll of sterile TSB was injected into
each fish. A total of 60 fish were used in each treatment
group (20 fish per tank, three replicates). At 14 and
28 days post vaccination (dpv), fish were challenged with
the virulent parent strain AH11P through IP injection.
Mortalities were recorded for 14 days postchallenge and
the presence or absence of Aer. hydrophila in dead fish was
determined as described earlier. Results of challenge were
presented as relative per cent of survival (RPS) as
described previously (Amend 1981). RPS was calculated
according to the following formula: RPS = [1  (vacci-
nated mortality  control mortality)] 9 100.
Colony size and cell size of AH11NOVO compared with
AH11P
To determine the colony size of AH11NOVO compared
with AH11P, both bacteria were cultured overnight in
TSB at 28°C. Optical density (OD) of the bacterial cul-
ture was measured at 540 nm and adjusted to OD = 10.
Serial dilutions of each strain (in triplicates) were then
prepared in TSB and 100 ll of serially diluted Aer.
hydrophila was immediately plated onto TSA plates. After
overnight growth, the colonies of AH11NOVO or AH11P
grown on TSA plates were photographed using Gel Logic
440 Imaging system (Kodak, New Haven, CT, USA). To
determine the cell size of AH11NOVO compared with
AH11P, equal volume of bacterial suspension in phos-
phate-buffered saline and 5% skim milk were mixed
together on clean microscope slides and then streaked
across the slides using a second slide in a swift motion.
After air drying, the slides were stained with Gram’s crys-
tal violet solution for 1–2 min. The excess stain was
washed off with 20% copper sulfate (CuSO4) solution
and the slides were air dried in a vertical position. The
cells were observed using an 1009 oil immersion lens
with a BX41 microscope (Olympus, Tokyo, Japan).
Cell growth and proliferation profile of AH11NOVO
compared with AH11P
Cell growth and proliferation assays were performed
using published procedures (Pridgeon et al. 2011).
Briefly, both AH11NOVO and AH11P were cultured
overnight in TSB at 28°C. Optical density (OD) of the
bacterial culture was measured at 540 nm and adjusted
to OD = 10. Serial dilutions of both AH11NOVO and
AH11P were prepared in TSB and six dilutions (1 : 20,
1 : 40, 1 : 80, 1 : 160, 1 : 320 and 1 : 640) were made in
triplicate in sterile 96-well microtitre plates. Plates were
incubated at 28°C with constant shaking and the optical
density at 540 nm was measured at different time points
(0-, 1-, 2-,3-, 4-, 5-, 6-, 7-, 23-, 24- and 25-h postincuba-
tion) using a Bio-Rad 680 microplate reader (Bio-Rad,
Hercules, CA, USA). The number of viable bacteria in
each well was then determined by CellTiter 96® AQueous
Non-Radioactive Cell Proliferation Assay (MTS; Pro-
mega) using published procedures (Pridgeon et al. 2011).
The optical density of the 96-well plate measured at
490 nm soon after MTS incubation was considered as the
0-h of the MTS incubation. Relative increased OD value
was calculated using the following formula: Increased OD
value = OD value after incubation  OD value at 0 h of
the incubation. The increased OD values after incubation
were then plotted against its respective incubation time.
In vitro motility of AH11NOVO and AH11P in semi-
solid agar medium
To determine the in vitro motility of AH11NOVO in
semi-solid agar medium, tryptic soy broth containing
agar at concentration of 25 g ml1 was prepared in
14-ml sterile culture tubes. Both AH11NOVO and
AH11P were cultured overnight in TSB at 28°C. Optical
density of the bacterial culture was measured at 540 nm
and adjusted to OD = 10. A 10-ll sterile loop was used
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to inoculate AH11NOVO or AH11P to the semi-solid
agar medium by stabbing through the centre of the med-
ium with inoculating needle reaching approximately half
of the depth of the medium. Each sample was inoculated
into four tubes. Inoculated test tubes containing the
semi-solid agar were then incubated at 28°C for 48 h.
After the 48 h incubation, in vitro motility results were
recorded using Logic 440 Imaging system (Kodak).
In vitro attachment and invasion of Aeromonas
hydrophila to G1B catfish gill cells
In vitro competitive attachment and invasion assays were
performed according to published procedures (Pridgeon
et al. 2011) with slight modifications. Briefly, catfish G1B
gill cells (American Type Culture Collection, Manassas,
VA, USA) in F-12K media were split into 48-well tissue
culture plates with final concentration of 1 9 105 cells
per well and grown at 25°C for 24 h. Overnight culture
of AH11NOVO and AH11P (OD = 08) were diluted to
1 : 10 and mixed at a ratio of 1 : 1. Mixed bacterial sam-
ples were added to 48-well plates that containing G1B gill
cells. Gill cells in the absence of any bacteria were used as
negative control. Plates were incubated at 25°C for 1 h.
For the attachment assay, the culture medium and unat-
tached bacteria were removed by washing each well three
times gently with 2 ml of 19 Hank’s balanced salt solu-
tion. Trypsin-EDTA was added to each well to detach
G1B gill cells from the culture plates. The solution in
each well containing G1B cells and any attached bacteria
were then serially diluted and plated on triplicate TSA
plates. For the invasion assay, culture medium containing
5 mg ml1 gentamicin (Sigma-Aldrich, St Louis, MO,
USA) was added to each well to kill any extracellular bac-
teria. Plates were incubated at 25°C for 1 h. The culture
medium containing gentamicin and any extracellular bac-
teria were then gently removed. TSB containing 01%
Triton X-100 (Sigma-Aldrich) was then added to each
well to release any intracellular bacteria inside G1B cells.
The solution was then serially diluted and plated onto
triplicate TSA plates. To determine the input number of
AH11NOVO and AH11P added to each well, serial dilu-
tions of each strain (in triplicates) were also prepared in
TSB and 100 ll of serially diluted Aer. hydrophila was
plated onto TSA plates. All TSA plates were incubated at
28°C for 24 h. To determine whether the attached or
invaded bacteria were AH11NOVO or AH11P, all indi-
vidual colonies grown on TSA were subsequently picked
to grow overnight in TSB in 96-well plate in the presence
and absence of novobiocin (96 mg ml1). The 96-well
plate was then incubated at 28°C. The number of colo-
nies that grew in the presence of 96 mg ml1 novobiocin
was counted as that of AH11NOVO. The colony number
of AH11P was calculated by using the following formula:
colony number of AH11P = total colony number  col-
ony number of AH11NOVO. The experiment was
repeated three times. The attachment and invasion rate of
AH11NOVO or AH11P was calculated using the follow-
ing formula: attachment or invasion rate = [(number of
attached or invaded bacteria)  total number of bacteria
added] 9 100%.
In vitro chemotactic response of AH11NOVO and
AH11P to catfish mucus
In vitro chemotaxis assays were performed according to
published procedures (Klesius et al. 2010). Briefly, healthy
channel catfish mucus was collected from the skin of the
catfish and the mucus proteins were prepared according to
published procedures (Klesius et al. 2010). The mucus
protein concentration was then determined using BCA
Protein assay (Pierce, Rockford, IL, USA) and adjusted to
02 mg ml1 with 19 PBS. Chemotaxis assay was per-
formed using blind-well chemotaxis chambers (Corning
CoStar, Cambridge, MA, USA) as described by Klesius
et al. (2010). Briefly, the bottom chambers were filled with
200 ll of either Aer. hydrophila (1 9 109 CFU ml1) par-
ent or vaccine strain. The bottom chamber was separated
from the upper chamber by an 8-lm pore diameter poly-
carbonate membrane filter (Nucleopore, Pleasontan, CA,
USA). Triplicate mucus samples (02 mg protein ml1)
were added to the upper compartment of the chamber of
each parent and vaccine strain. As negative controls, lower
chamber with tryptic soy broth and upper chamber with
mucus samples was also included in the assay. The cham-
bers were incubated for 90 min at 28°C on a horizontal
platform shaker. Following incubation, 100 ll was trans-
ferred to a flat-bottom 96-well microtitre plate (Thermo
Scientific, Milford, MA, USA). The number of viable bacte-
rial cells in each well was then determined by CellTiter 96®
AQueous Non-Radioactive Cell Proliferation Assay (MTS)
using published procedures (Pridgeon et al. 2011). Relative
increased OD value was calculated using the following
formula: DOD 490 nm (sample) = OD 490 nm value
(after incubation)  OD 490 nm value (0 h of the incuba-
tion). The relative chemotaxis index of AH11NOVO or
AH11P to fish mucus was calculated using the following
formula: DD chemotaxis index = DOD 490 nm of test
sample (AH11NOVO or AH11P) – DOD 490 nm of
mucus sample alone (without bacteria in the lower
chamber). The experiments were repeated four times.
Statistical analysis
All statistical analyses were performed using SIGMASTAT
35 software (Systat Software, Inc, Point Richmond, CA,
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USA). Differences in cell growth, cell proliferation, che-
motaxis, attachment and invasion were analysed using
Student t-test and the significance level was defined as
P < 005.
Results
FAME profiles and partial DNA gyrase B sequencing of
AH11NOVO and AH11P
MIDI microbial identification system revealed that both
AH11NOVO and AH11P shared high similarity indices
(0488 and 0481, respectively) with Aer. hydrophila
deposited at the RCLN50 database. The FAME profile of
AH11NOVO and AH11P are shown in Fig. 1. Of all the
fatty acids, the percentage/peak of 16 : 1 w7c/16 : 1 w6c
fatty acid in AH11P was the highest (3718%), followed
by the peak of 16 : 0 fatty acid (2097%) and 18 : 1 w7c
fatty acid (1949%). Similarly, the major fatty acids in
AH11NOVO were 16 : 1 w7c/16 : 1 w6c fatty acid
(3780%), 16 : 0 fatty acid (2216%) and 18 : 1 w7c fatty
acid (1916%). DNA sequencing results revealed that both
AH11NOVO and AH11P shared 99% similarities with
the DNA gyrase B gene of Aer. hydrophila subsp. hydro-
phila ATCC 7966 (GenBank accession no. CP000462),
with e-value of 0.
Virulence of AH11NOVO compared with AH11P
Virulence of AH11NOVO and AH11P to channel catfish
was summarized in Table 1. All dead fish after exposure
to AH11P or AH11NOVO throughout this study were
culture positive for Aer. hydrophila. At injection doses of
10 9 108 CFU per fish, the parent strain AH11P killed
100% fish (Table 1). However, when higher amounts
16 9 108 CFU per fish of novobiocin-resistant
AH11NOVO were injected to fish, no fish died (Table 1).
Vaccination with AH11NOVO followed by challenge
with AH11P
When novobiocin-resistant AH11NOVO vaccinated chan-
nel fish were challenged with its virulent parent AH11P
at 14 dpv, RPS of vaccinated fish was 100% (Table 2).
When AH11NOVO vaccinated channel fish were chal-
lenged with AH11P at 28 dpv, RPS of vaccinated fish
ranged from 50 to 875% (Table 2). When AH11NOVO
vaccinated fish or TSB sham-vaccinated fish were chal-
lenged with AH11P at 14 dpv, the cumulative mortalities
of AH11NOVO vaccinated fish at different time points
after challenge were significantly (P < 005) lower than
that of TSB sham-vaccinated fish (Fig. 1a). Similarly, at
28 dpv, the cumulative mortalities of AH11NOVO
vaccinated fish at different time points after challenge
with AH11P were significantly (P < 005) lower than that
of TSB sham-vaccinated fish (Fig. 1b).
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Figure 1 Daily mean per cent cumulative mortality of channel catfish
intraperitoneally vaccinated with or without Aeromonas hydrophila
AH11NOVO and challenged with Aer. hydrophila AH11P through
intraperitoneal injection. (a) Fourteen days post vaccination; (b)
28 days post vaccination. Daily mean per cent cumulative mortalities
were calculated from three vaccination trials. (●) TSB sham vaccinated
fish and (○) AH11NOVO vaccinated fish.
Table 1 Virulence of novobiocin-resistant Aeromonas hydrophila
AH11NOVO and its parent isolates AH11P to channel catfish by
intraperitoneal injection
Isolate name Injection dose (CFU per fish) Mortality ± SD (%)
AH11NOVO 16 9 108 0 ± 0
AH11P 10 9 108 100 ± 0
AH11NOVO 80 9 107 0 ± 0
AH11P 50 9 107 87 ± 12
AH11NOVO 16 9 107 0 ± 0
AH11P 10 9 107 0 ± 0
TSB 0 0 ± 0
Untreated 0 0 ± 0
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Colony size and cell size of AH11NOVO compared with
AH11P
When similar amount of AH11NOVO and AH11P were
distributed onto TSA plates and incubated at 28°C for
24 h, AH11P appeared to be larger in colony size
(Fig. 2a). However, morphologically, both colonies
appeared to have a smooth surface (Fig. 2a). Under the
microscope, the cell size of AH11NOVO appeared to be
smaller than that of AH11P (Fig. 2b), but the thickness
of the cell walls of AH11NOVO appeared to be similar to
that of AH11P (Fig. 2c).
Cell proliferation profile of AH11NOVO compared with
AH11P
At OD 540 nm = 10, the average amount of AH11P
was 101 ± 011 9 109 CFU ml1, whereas that of
AH11NOVO was 170 ± 020 9 109 CFU ml1. When
the starting amount of bacteria of both AH11NOVO and
AH11P was at 1 : 160 dilution from OD 540 nm = 10,
the relative increase in OD 540 nm values of AH11P at
1- and 2-h postincubation appeared to be lower than that
of AH11NOVO (Fig. 3a). However, at 3-h postincubation
and later time points, the relative increase in OD 540 nm
value of AH11P was significantly (P < 005) higher than
that of AH11NOVO (Fig. 3a). Similar pattern was also
observed when the starting amount of both bacteria in
each well was at other dilutions (data not shown). Cell
proliferation assays revealed that the relative increase in
OD 490 nm value of AH11P was significantly (P < 005)
higher than that of AH11NOVO at 5-, 6-, 7- and 23-h
post-MTS incubation (Fig. 3b). However, at both
24- and 25-h post-MTS incubation, the relative increase
in OD 490 nm value of AH11P was not significantly
different from that of AH11NOVO (Fig. 3b).
Table 2 Cumulative mortality and relative per cent survival of AH11NOVO vaccinated catfish challenged with AH11P
Trial No. Vaccine group
Vaccine dose
(CFU per fish)
Isolate used
for challenge
Challenge dose
(CFU per fish) dpv Mortality (%) RPS (%)
I Sham TSB – AH11P 50 9 107 14 100 –
I AH11NOVO 16 9 108 AH11P 50 9 107 14 0 100
II Sham TSB – AH11P 50 9 107 14 80 –
II AH11NOVO 16 9 108 AH11P 50 9 107 14 0 100
III Sham TSB – AH11P 50 9 107 14 80 –
III AH11NOVO 16 9 108 AH11P 50 9 107 14 0 100
I Sham TSB – AH11P 50 9 107 28 80 –
I AH11NOVO 16 9 108 AH11P 50 9 107 28 10 875
II Sham TSB – AH11P 50 9 107 28 80 –
II AH11NOVO 16 9 108 AH11P 50 9 107 28 40 50
III Sham TSB – AH11P 50 9 107 28 80 –
III AH11NOVO 16 9 108 AH11P 50 9 107 28 10 875
dpv, days post vaccination; RPS, relative per cent of survival; TSB, tryptic soy broth.
AH11P(a)
(b)
(c)
AH11NOVO
AH11P AH11NOVO
AH11P
50·0 µm 50·0 µm
50·0 µm50·0 µm
AH11NOVO
Figure 2 Colony size and cell size of AH11NOVO compared to
AH11P. (a) Overnight growth on blood agar plates; (b) Intact cells
under microscope; (c) Cell wall stripped cells under microscope.
Pictures shown were representatives of four replicates. Scale bar:
50 lm.
1324 Journal of Applied Microbiology 113, 1319--1328 © 2012 No claim to US Government works
Characterize novobiocin-attenuated Aer. hydrophila AH11NOVO J.W. Pridgeon et al.
In vitro motility of AH11NOVO and AH11P in
semi-solid agar medium
When grown in semi-solid agar medium, the virulent
parent strain of Aer. hydrophila AH11P showed diffused
growth throughout the entire medium, whereas the novo-
biocin-resistant AH11NOVO only showed growth
confined to the line of inoculation.
In vitro attachment and invasion of AH11NOVO and
AH11P to G1B gill cells
The in vitro adhesion and invasion abilities of
AH11NOVO and AH11P to catfish G1B gill cells are sum-
marized in Fig. 4. Of the 13 9 107 CFU of AH11P added
to each well of G1B cells, 80 ± 20 9 104 CFU attached
to G1B cells, with the per cent of AH11P attached to G1B
cells at 062 ± 015%. Of the 24 9 107 CFU of
AH11NOVO added to each well of G1B cells,
20 ± 08 9 105 CFU attached to G1B cells, with the per
cent of AH11NOVO attached to G1B cells at
083 ± 033%. Therefore, on average, the attachment rate
of AH11NOVO was higher than that of AH11P. However,
there was no significant difference between the attachment
rate of AH11NOVO and that of AH11P (Fig. 4a). The
invasion rate of AH11P to G1B gill cells was
0036 ± 0025%, which was significantly (P < 005) higher
than that of AH11NOVO (00014 ± 00016%; Fig. 4b).
In vitro chemotactic response of AH11NOVO and
AH11P to catfish mucus
The results of the in vitro chemotactic response of
AH11NOVO and AH11P to catfish mucus are summa-
rized in Fig. 5. The average chemotactic index of AH11P
to catfish mucus was 230 ± 036, which was significantly
(P < 005) higher than that of AH11NOVO (136 ± 038;
Fig. 5).
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Figure 3 Cell growth and proliferation of AH11NOVO and AH11P.
(a) Relative cell growth determined by the turbidity measured at
540 nm; (b) Relative cell proliferation determined by MTS assay mea-
sured at 490 nm. Data were presented as mean ± standard deviation
(SD) from three replicates. (●) AH11P and (○) AH11NOVO.
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Figure 4 Per cent of AH11NOVO and AH11P attached or invaded to
catfish G1B gill cells. (a) Percent of attachment; (b) Percent of inva-
sion. The per cent of the amount of bacteria (colony forming unit,
CFU) attached or invaded to G1B cell was determined by surface plat-
ing of bacteria onto tryptic soy agar (TSA) plates. Data are presented
as mean ± standard deviation (SD) from three replicates. Significant
difference (P < 005) was marked by asterisk.
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Discussion
Virulence study revealed that AH11P killed 100% channel
catfish at dose of 10 9 108 CFU per fish. However, at
dose of 10 9 107 CFU per fish, AH11P failed to kill any
catfish used in this study. The LD95 dose of another
pathogenic strain of Aer. hydrophila AL98-C1B was
reported to be 20 9 108 CFU per fish (Pridgeon and
Klesius 2011a). However, the LD95 doses of the highly
virulent 2009 west Alabama isolates of Aer. hydrophila
AL98-C1B were 48 9 105–70 9 105 CFU per fish
(Pridgeon and Klesius 2011a). Taken together, these
results suggest that AH11P was not a highly virulent
strain of Aer. hydrophila.
Using novobiocin-resistant strategy, a novel attenuated
Aer. hydrophila strain AH11NOVO was obtained from a
virulent strain AH11P after 20 passages in novobiocin-
containing media. The virulent parent strain AH11P was
only able to survive in TSB containing 10 lg ll1 of
novobiocin, but the novobiocin-resistant Aer. hydrophila
AH11NOVO was able to grow in TSB containing
9600 lg ll1 of novobiocin, suggesting that the novel
strain of Aer. hydrophila AH11NOVO was at least 960
times more resistant to novobiocin than its parent strain
AH11P. AH11NOVO was found to be avirulent to chan-
nel catfish when injected at 24 9 108 CFU per fish,
whereas AH11P at similar and lower dose killed 100%
fish, suggesting that the trait of novobiocin resistance in
AH11NOVO might have resulted in the attenuation of
virulence as one of its fitness costs. This is not surprising
as decreased virulence as a fitness cost has been reported
in novobiocin-resistant Edw. ictaluri (Pridgeon and
Klesius 2011b) and Strep. iniae (Pridgeon and Klesius
2011c). In addition, decreased virulence of Staphylococcus
aureus has been reported to be associated with antibiotic
resistance (McCallum et al. 2006). Differential transcrip-
tome analysis on teicoplanin-resistant Staph. aureus has
revealed that as resistance to antibiotic teicoplanin
increased, some virulence-associated genes were down-
regulated (McCallum et al. 2006). These results suggest
that the gain of antibiotic resistance might result in the
attenuation of virulence in bacteria. However, the gain of
antibiotic resistance in bacteria does not necessarily lead
to the attenuation of virulence, because it has been
reported that gain of novobiocin resistance trait in
Strep. iniae isolates such as Kent 02, Uruguay 1, Uruguay
A and 15Br failed to lower their virulence (Pridgeon and
Klesius 2011c). Therefore, the gain of antibiotic resistance
trait in bacteria does not necessarily lead to the
attenuation of its virulence.
When novobiocin-resistant AH11NOVO vaccinated
channel fish were challenged with its virulent parent
AH11P at 14 dpv, RPS of vaccinated fish was 100%.
However, when AH11NOVO vaccinated channel fish
were challenged with AH11P at 28 dpv, RPS of vacci-
nated fish decreased from 100 to 875% or 50%.
Decreased protection to channel catfish offered by attenu-
ated Aer. hydrophila vaccine at 28 dpv compared with
that at 14 dpv has been previously reported (Pridgeon
and Klesius 2011d), suggesting that booster immunization
of AH11NOVO such as oral vaccination after 14 dpv
might be necessary to increase its duration of protection.
Cell growth studies revealed that AH11NOVO strain
had a much lower growth rate as indicated by its smaller
colony size on agar plates and slower cell proliferation
profile. Slower growth has been reported as a fitness cost
in antibiotic-resistant bacteria (Han et al. 2009; Pridgeon
and Klesius 2011b,c,d). For example, the macrolide-resis-
tant Campylobacter jejuni has a slower growth rate than
that of its parent strain, with an average doubling time of
136 vs 112 min for the parent strain (Han et al. 2009).
Taken together, the smaller colony size of AH11NOVO
compared with its parent strain AH11P suggests that its
slower growth rate might be a fitness cost associated with
its resistance to novobiocin.
When grown in semi-solid agar medium, the virulent
parent strain of Aer. hydrophila AH11P showed diffused
growth throughout the entire medium, whereas the
novobiocin-resistant AH11NOVO only showed growth
confined to the line of inoculation, suggesting that
AH11P was motile, whereas AH11NOVO was not. In
vitro invasion studies revealed that the invasion rate of
AH11P to G1B gill cells was significantly higher than
that of AH11NOVO. In vitro chemotaxis assays revealed
that AH11P had significantly higher chemotactic
response to catfish mucus than AH11NOVO. As AH11P
was virulent to catfish whereas AH11NOVO was aviru-
lent to catfish, these results taken together suggest that
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Figure 5 Chemotactic response of Aeromonas hydrophila
AH11NOVO and AH11P to channel catfish mucus. Data were
presented as mean ± standard deviation (SD) from four replicates.
Significant difference (P < 005) was marked by asterisk.
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cell motility, cell invasion ability and chemotactic
response to host are all important virulence factors of
Aer. hydrophila. Although cell motility and invasion abil-
ity are well known virulence factors (Josenhans and Suer-
baum 2002; Zakikhany et al. 2008), the importance of
chemotaxis affecting the virulence of pathogens are not
extensively studied. It has been suggested that chemotaxis
is not necessary for Aer. hydrophila to become patho-
genic to common carp, but may be a necessary parame-
ter for Aer. hydrophila to become an obligate pathogen
(van der Marel et al. 2008). In vitro attachment assay
revealed that the attaching ability of AH11NOVO to
G1B gill cells was not significantly different from that of
AH11P, suggesting that attachment ability is not directly
linked to virulence. Electron microscopy studies have
demonstrated that all motile aeromonads produce fimb-
riae (pili) that facilitate adhesion, regardless of their viru-
lence (del Corral et al. 1990). Taken together, these
results suggest that chemotaxis, motility, and attachment
are all important factors for pathogens to locate the host
and attach to the host, but the ability to invade the host
and factors such as extracellular products might be
directly linked to virulence.
In summary, a novobiocin-resistant strain AH11NOVO
was obtained from a virulent Aer. hydrophila strain
AH11P through selection of resistance to novobiocin.
AH11NOVO provide significant protection to channel
fish against AH11P challenge. The cell proliferation rate
and chemotactic response of AH11NOVO was found to
be significantly lower than that of AH11P. Although the
ability of AH11NOVO to attach catfish gill cells was simi-
lar to that of AH11P, the ability of AH11NOVO to
invade catfish gill cells was significantly lower than that
of AH11P. Taken together, these results suggest that che-
motaxis, motility and attachment are all important fac-
tors for Aer. hydrophila to locate the host and eventually
attach to the host, but the ability to invade the host
might be directly linked to virulence.
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